scanX
Home
Gufic BioSciences

Gufic BioSciences

432.30
-9.65
(-2.18%)
Live Chart
comparison:

Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Revenue
36
38
52
56
57
55
65
65
63
61
77
90
80
79
93
88
95
93
88
101
88
62
131
167
133
252
194
174
162
166
176
178
174
196
215
202
196
204
204
Expenses
33
34
47
51
51
49
58
58
59
53
66
77
70
70
80
76
79
80
76
86
75
58
99
139
108
205
158
139
130
132
142
143
141
160
176
165
161
167
166
EBITDA
3
4
5
6
6
7
7
7
4
9
11
13
11
9
13
12
16
13
12
15
14
4
32
28
24
47
36
34
33
34
33
35
33
36
40
37
35
37
39
Operating Profit %
8 %
10 %
8 %
10 %
11 %
11 %
10 %
10 %
5 %
12 %
13 %
14 %
11 %
11 %
13 %
14 %
14 %
13 %
12 %
12 %
14 %
6 %
23 %
16 %
18 %
18 %
18 %
19 %
20 %
20 %
19 %
19 %
19 %
18 %
18 %
18 %
18 %
18 %
19 %
Depreciation
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
2
1
3
2
4
4
5
3
5
4
4
5
5
4
5
6
6
4
4
4
4
4
4
Interest
1
1
1
1
2
1
1
2
2
2
3
2
3
2
3
2
3
3
4
4
4
3
4
4
3
1
2
1
1
1
2
2
3
4
5
3
4
5
5
Profit Before Tax
1
2
3
3
4
4
4
4
1
6
7
10
7
6
10
9
11
9
6
9
6
-3
23
21
17
42
30
29
26
28
27
27
24
28
31
30
27
28
29
Tax
0
1
1
1
1
2
2
1
2
2
3
4
3
2
3
3
3
4
0
3
-0
0
4
5
2
11
8
7
7
7
8
7
6
7
5
7
7
7
8
Net Profit
1
1
2
2
2
3
3
3
1
4
6
6
1
4
6
6
6
7
4
7
5
-1
17
16
13
31
23
21
20
21
20
20
18
21
23
22
20
21
22
EPS in ₹
0.14
0.13
0.21
0.31
0.29
0.33
0.34
0.40
0.10
0.46
0.71
0.75
0.13
0.47
0.79
0.76
0.77
0.88
0.55
0.90
0.51
-0.15
1.79
1.60
1.33
3.22
2.41
2.17
2.09
2.17
2.09
2.10
1.87
2.13
2.39
2.23
2.00
2.08
2.17
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
127
152
179
238
280
408
392
521
861
1,093
Fixed Assets
25
22
22
23
24
83
100
115
160
159
Current Assets
92
120
143
198
233
273
261
321
464
601
Capital Work in Progress
0
0
0
2
10
31
13
41
170
307
Investments
0
0
0
0
0
0
0
0
1
2
Other Assets
102
130
157
213
246
294
279
365
531
625
Total Liabilities
127
152
179
238
280
408
392
521
861
1,093
Current Liabilities
84
104
128
169
186
240
164
186
288
372
Non Current Liabilities
17
15
13
15
18
38
55
66
225
188
Total Equity
27
34
37
54
75
129
173
269
348
533
Reserve & Surplus
19
26
30
46
68
120
164
259
338
523
Share Capital
8
8
8
8
8
10
10
10
10
10
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
4
-0
-1
1
-0
0
2
5
17
-28
Investing Activities
-2
-1
-5
-9
-13
-43
-7
-95
-191
-102
Operating Activities
11
-4
-4
-5
5
47
87
106
-27
-8
Financing Activities
-5
5
7
14
8
-4
-79
-6
234
82
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Oct 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Promoter
65.75 %
65.13 %
75.48 %
75.48 %
75.48 %
75.00 %
75.00 %
75.00 %
75.00 %
75.00 %
75.00 %
72.51 %
72.51 %
72.51 %
72.51 %
72.51 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.72 %
0.00 %
0.12 %
0.23 %
0.24 %
DIIs
8.25 %
3.24 %
2.13 %
1.19 %
1.03 %
1.03 %
1.16 %
1.16 %
1.16 %
1.16 %
1.50 %
1.58 %
1.60 %
2.20 %
2.39 %
2.51 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
21.92 %
27.67 %
17.00 %
17.40 %
17.65 %
17.84 %
18.29 %
18.24 %
17.83 %
17.84 %
17.16 %
16.66 %
16.85 %
16.72 %
16.36 %
16.01 %

Dividend History

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
Sun Pharmaceutical
1,808.85 4,37,470.70 39.03 49,887.20 12.06 9,648 27.34 50.79
Cipla
1,472.05 1,21,662.90 26.34 26,520.70 14.17 4,155 12.95 46.11
Mankind Pharma
2,805.20 1,15,828.20 54.73 10,615.60 19.57 1,942 28.89 61.57
Dr Reddys Laboratories
1,343.65 1,10,601.40 20.73 28,905.40 12.36 5,578 -9.47 69.74
Zydus Life Science
973.50 99,174.40 23.19 19,831.50 13.82 3,831 14.57 47.78
Lupin
2,150.70 98,655.70 37.56 20,141.50 19.94 1,936 73.53 56.33
Aurobindo Pharma
1,241.70 72,873.20 20.17 29,559.20 17.55 3,169 8.66 44.58
Alkem Laboratories
5,427.50 65,692.00 30.23 12,978.40 9.84 1,812 14.16 41.78
Glenmark Pharmaceuticals
1,541.65 43,479.60 - 12,653.10 6.58 -1,831 675.49 48.06
Biocon
335.95 42,063.00 30.18 15,621.20 35.25 1,298 -84.31 38.88

Corporate Action

Technical Indicators

RSI(14)
Neutral
49.24
ATR(14)
Volatile
19.59
STOCH(9,6)
Neutral
36.26
STOCH RSI(14)
Neutral
61.08
MACD(12,26)
Bullish
0.08
ADX(14)
Strong Trend
30.74
UO(9)
Bearish
42.65
ROC(12)
Downtrend And Accelerating
-2.88
WillR(14)
Neutral
-58.80
Bearish
3
Neutral
4
Bullish
2
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore   |   Sitemap
Price & Volume Screeners
Intraday Screeners
Candlestick Screeners
Fundamental Screeners
Technical Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.

© 2024 Moneylicious Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

Corporate Office: A-302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai – 400066, Maharashtra, India. Land Line: 022-43116666.